Immunohistochemical study on inducible type of nitric oxide (iNOS), basic fibroblast growth factor (bFGF) and tumor growth factor-β1 (TGF-β1) in arteritis induced in rats by fenoldopam and theophylline, vasodilators

Experimental and Toxicologic Pathology

Volumn 54, Issue 1, 2002, Pages 1-7

  Ikegami, Hisashi ^a,b   Kajikawa, Satoru ^a   Ito, Kyoko ^a   Nii, Aisuke ^a   Okamiya, Hideaki ^a   Nakayama, Hiroyuki ^b   Doi, Kunio ^a  

^a ASTELLAS PHARMA INC   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Arteritis; Basic fibroblast growth factor (bFGF); Fenoldopam; Immunohistochemistry; Inducible type of nitric oxide (iNOS); Rat; Theophylline; Tumor growth factor 1 (TGF 1); Vasodilator

Indexed keywords

ANTIGEN; BASIC FIBROBLAST GROWTH FACTOR; CANCER GROWTH FACTOR; FENOLDOPAM; NITRIC OXIDE SYNTHASE; THEOPHYLLINE; VASODILATOR AGENT; FIBROBLAST GROWTH FACTOR 2; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERITIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; RAT; ANIMAL; ARTERY; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; DRUG EFFECT; FISCHER 344 RAT; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; ORAL DRUG ADMINISTRATION; PANCREAS; PATHOLOGY; VASCULARIZATION;

ANIMALIA;

ADMINISTRATION, ORAL; ANIMALS; ARTERIES; ARTERITIS; DRUG THERAPY, COMBINATION; FENOLDOPAM; FIBROBLAST GROWTH FACTOR 2; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PANCREAS; RATS; RATS, INBRED F344; THEOPHYLLINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASODILATOR AGENTS;

EID: 0035990456     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1078/0940-2993-00238     Document Type: Article

References (22)

1. Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine
2. Tissue preparation methods for immunochemistry
3. Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat
4. Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy
5. Macrophage deactivating factor and transforming growth factors-1, -2 and -3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma
6. Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions
7. Expression of inducible nitric oxide synthase in spontaneous bovine bronchopneumonia
8. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented cells: Inverse correlation with cellular proliferation
9. Characterization of the arteritis induced by infusion of rats with UK-61,260, an inodilator, for 24h. A comparison with the arteritis induced by fenoldopam mesylate
10. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes: Potential role for nitric oxide in the regulation of wound healing
11. Histopathological and immunohistochemical studies on arteritis induced by fenoldopam, a vasodilator, in rats
12. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat
13. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat
14. Drug-induced lesions, arteritis, rat
15. Inducible nitric oxide production and expression of transforming growth factor-β1 in serum and CSF after cerebral ischaemic stroke in man
16. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis
17. Theophylline-induced mesenteric periarteritis in F344/N rats
18. Molecular and metabolic evidence for the restricted expression of inducible nitric oxide synthase in healing wounds
19. Control of nitric oxide production by transforming growth factor-β1: Mechanistic insights and potential relevance to human disease
20. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-β1
21. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor-β1 null mouse
22. Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator